HMD faces Manpower challenges To reach 1 Billion Syringes by June 2021 For Supporting the Covid Vaccination Drive
HMD on recruitment drive of 500 people to increase production capacityofAuto Disable Syringes to 100 Crore by June 2021 HMD timely delivers 21.75 Crore syringesby April end to GoI As Hindustan Syringes & Medical Devices
- HMD on recruitment drive of 500 people to increase production capacityofAuto Disable Syringes to 100 Crore by June 2021
- HMD timely delivers 21.75 Crore syringesby April end to GoI
As Hindustan Syringes & Medical Devices Ltd (HMD) strives to increase production of Auto Disable syringes to 1 Billion pcs per annum by June 2021, to support the massive vaccination campaign to eradicate Covid-19, one major ongoing concern raised by Mr. Rajiv Nath, Managing Director of Hindustan Syringes & Medical Devices Ltd. is that instead of the employment going up it has been going down for the last 6 weeks due to the ongoing second wave of Covid as well as workers on leave for ongoing Panchayat elections, harvesting &wedding season in UP. Manpower shortage has hit the organization and production.
“We have currently extreme shortages of manpower. To reach our target of 100 crore syringes capacity, HMD needs to strengthen our team and employ 3200 people but currently have on roll 2700. We are 500 people short to achieve our target of 100 Crore pcs of AD syringes by June this year.”said Mr. Rajiv Nath, Managing Director of Hindustan Syringes & Medical Devices Ltd.
“Our role is akin to supplying guns to soldiers in the battleground, the vaccines are the bullets. We are in the process of immediate recruitment of 500 people to increase production at our factories in Faridabad industrial district in Haryana.We are looking forhardworking sincere people fromstates like Haryana, Himachal Pradesh, UP and Rajasthan that are high school pass and fresher who we will train with requisite skills. We have air cooled and air conditioned factories with good management and cooperative staff that trains and teaches unskilled youngsters to work on various automatic machines and ensure quality output as we are making life saving medical products in hygienic environment. HMD is ensuring complete protection of the health, safety &wellbeing of each of its employees by enforcing discipline and adherence to best practices to prevent Covid at workplace. It’s a noble cause, we know our responsibilities.” added Mr. Nath.
Hindustan Syringes & Medical Devices Ltd (HMD), is a reputed leading manufacturer of Disposable Syringes in the World and possibly the largest for Kojak Auto Disable syringes that is making India proud with its global recognition as a key international supplier of critically needed syringes to COVAX facility of WHO (via UNICEF) , Brazil and even Japan for Covid Vaccination while being on track to timely supply the 4 orders received from GoI on 0.5 ml AD syringes totaling 44.25 Crore pcs of which 21.75 Crore pcs has been supplied by April end to help in vaccinating India against Covid and balance by September .
Last year in December, HMD has also already dispatched 14 Crore AD syringes to the COVAX stockpile Facility created in anticipation for supporting global worldwide Vaccination Drive.
“This is in addition to our ongoing global contractual commitments to support global vaccination projects for 0.1ml & 0.5 ml AD Kojak syringes in developing world whether for Yellow Fever or Measles or Hepatitis B or Pentavalent or BCG etc in addition to Covid vaccination requirements of 0.3ml AD syringes for Pfizer’s vaccines or 0.5 ml AD Kojak for Astra Zeneca/ Serums or Bharat Biotech’s vaccines. However this year our focus isIndia as our country needs come 1st. We have reserved over 2/3rd capacity for India and declined orders from many overseas new potential buyers” said Mr. Rajiv Nath.
From 50 Crore pcs per annum capacity of 0.5 ml AD Syringes in June 2020 we are currently producing at rate of 80 Crore per annum & hope to create capacity of 100 Crore by June end & hopefully120 Crore pcs per annum by September this year, for this one size alone. 0.5ml is the size sought by Public Healthcare in India and most countries for Covid. For Private Healthcare the Dispovan Disposable Syringes are still popular but we see a shift by the progressive hospitals (who wish to assure their patients of higher injection safety) for auto disable syringes that ensure One Injection One Syringe.
Now our machines crank out more than 3.75 lac syringes of various types per hour at our factories spread over 11 acres in Faridabad industrial district in Haryana. HMD had capacity to produces over 250 Crore assorted syringes of various types and sizes per year & we are investing over ₹100 Crore from our own resources, without govt. supportfor scaling this up to 300 croreby July in our sincere quest for ensuring no shortages in India.
In Covid times it’s been challenging to ramp up capacity as the precision engineering demands are tremendous at these high speeds of production for which our suppliers in Switzerland, Germany Italy, Japan etc usually take 9-12 months and not only do we need to do capital investments to increase the syringes production but also for the needles used to assemble with them and then for the cannula – needle points grinding that’s needed to make the needles and then even the stainless steel capillary tubing that’s required to make these Cannulas (needle points) as we are fully vertically integrated and make our own raw materials as we always had followed the philosophy to be Atmanirbhar.” said Mr.Nath.
With over 9 plants, HMD has created a niche for their disposable syringe ―DISPOVAN which is today the most popular brand in syringe market in India with over 60% market share with DispoVan Needle and DispoVan Insulin Syringes having over 70% Market Share and thereby displaced renowned MNC‘s – an inspirational case study for other Indian entrepreneurs.
“We urge all the eligible citizens of India to get vaccinated against covid-19 and we assure our full support to the State & the Central Govt. to combat the crisis.” concluded Mr. Nath.